TendieTensor TendieTensor
You’re browsing as
Guest
Free Preview
Sign in/sign up to unlock all features.

News  ›  GlobeNewswire Inc.

Calidi Biotherapeutics Announces Exclusive Live Investor Webinar and Q&A Session on November 19, 2025

GlobeNewswire Inc. Logo GlobeNewswire Inc. By Dave Gentry
Calidi Biotherapeutics Announces Exclusive Live Investor Webinar and Q&A Session on November 19, 2025

Calidi Biotherapeutics is hosting an investor webinar to discuss its RedTail platform, an engineered viral therapy designed to deliver genetic medicines to tumor sites. The company aims to advance its technology towards IND filing by end of 2026, targeting oncology markets projected to exceed $560 billion by 2033.

Insights
CLDI   positive

Company is showcasing promising preclinical data, advancing towards IND filing, has a strengthened balance sheet, and is targeting a large potential market in oncology